Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients

NCT04565496 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Study related: Study terminated early due to protocol evolution from neoadjuvant to perioperative design, feasibility and recruitment concerns, and regulatory constraints requiring substantial amendments and additional procedures.

Conditions

Interventions

Sponsor

IRCCS San Raffaele